Clinical Performance of a Daily Disposable Toric Silicone Hydrogel Contact Lens
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to obtain on-eye clinical performance data to evaluate the stability of axis orientation of DDT2 toric contact lenses in the intended population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2020
CompletedFirst Posted
Study publicly available on registry
July 9, 2020
CompletedStudy Start
First participant enrolled
July 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 6, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 6, 2020
CompletedAugust 19, 2020
August 1, 2020
17 days
July 7, 2020
August 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent of lenses with axis orientation within ±30° from the intended axis, 10 minutes after lens insertion
Axis orientation (orientation of the scribe mark) will be assessed by slit lamp examination and recorded as deviations from intended axis.
Day 1, 10 minutes after lens insertion
Study Arms (1)
DDT2 Toric
EXPERIMENTALVerofilcon A toric contact lenses worn in both eyes
Interventions
Daily disposable toric soft contact lenses
Eligibility Criteria
You may qualify if:
- Able to understand and sign an informed consent form;
- Successful wear of spherical or toric soft contact lenses in both eyes, as specified in the protocol;
- Willing to NOT use rewetting/lubricating drops at any time during the study;
You may not qualify if:
- Any eye condition that would contraindicate contact lens wear, as determined by the Investigator;
- History of eye surgery within the previous 12 months, as specified in the protocol;
- Current or history of dry eye in either eye that, in the opinion of the Investigator, would preclude contact lens wear;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alcon Researchlead
Study Sites (1)
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, 76134, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Trial Lead, Vision Care
Alcon Research, LLC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2020
First Posted
July 9, 2020
Study Start
July 20, 2020
Primary Completion
August 6, 2020
Study Completion
August 6, 2020
Last Updated
August 19, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share